CGEM Smart Money
Cullinan Therapeutics, Inc.
1W: +0.1%
1M: -0.7%
3M: -13.8%
YTD: +46.6%
1Y: +91.2%
3Y: +70.0%
5Y: -31.0%
$14.84
+0.30 (+2.06%)
Pre-Market: $15.40 (+0.56, +3.77%)
Weekly Expected Move ±9.6%
$12
$13
$14
$16
$17
Credit Risk of going bust: lower than 76% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Cullinan Therapeutics, Inc. would be worth roughly what it owes.
Total debt $2.1M against a stock market value of $912.0M.
Distance to default 8.84 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $702K (short-term plus half of long-term), stock volatility 78.2%; Altman Z'' 3.42. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Cullinan Therapeutics, Inc. would be worth roughly what it owes.
Total debt $2.1M against a stock market value of $912.0M.
Distance to default 8.84 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $702K (short-term plus half of long-term), stock volatility 78.2%; Altman Z'' 3.42. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026206
Institutions Holding
+17 vs prior
136.2%
Ownership
+37.34%
35
New
83
Increased
67
Reduced
20
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 8,000 | $21.57 | $173K | Filing |
| 2026-08-13 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 30,000 | $20.26 | $608K | Filing |
| 2026-07-06 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 8,000 | $17.82 | $143K | Filing |
| 2026-06-30 | SUMER JACQUELYN L | officer: chief legal officer | A-Grant/Award | 2,470 | $8.60 | $21K | Filing |
| 2026-06-30 | Fenton Mary Kay | officer: chief financial officer | A-Grant/Award | 1,541 | $8.60 | $13K | Filing |
| 2026-05-05 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 200 | $15.58 | $3K | Filing |
| 2026-05-05 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 7,800 | $14.60 | $114K | Filing |
| 2026-02-25 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 1,780 | $14.14 | $25K | Filing |
| 2026-02-24 | SUMER JACQUELYN L | officer: chief legal officer | S-Sale | 3,601 | $14.47 | $52K | Filing |
| 2026-02-24 | AHMED NADIM | officer: president and ceo | S-Sale | 13,515 | $14.47 | $196K | Filing |
| 2026-02-24 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 3,601 | $14.47 | $52K | Filing |
| 2026-02-24 | Jones Jeffrey Alan | officer: chief medical officer | S-Sale | 4,582 | $14.47 | $66K | Filing |
| 2026-02-23 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 1,752 | $13.99 | $25K | Filing |
| 2026-02-20 | Fenton Mary Kay | officer: chief financial officer | S-Sale | 4,398 | $13.62 | $60K | Filing |
| 2026-02-20 | Jones Jeffrey Alan | officer: chief medical officer | S-Sale | 4,982 | $13.62 | $68K | Filing |
| 2026-02-20 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 8,000 | $14.30 | $114K | Filing |
| 2026-02-20 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 3,742 | $13.62 | $51K | Filing |
| 2026-02-20 | SUMER JACQUELYN L | officer: chief legal officer | S-Sale | 3,742 | $13.62 | $51K | Filing |
| 2026-02-20 | AHMED NADIM | officer: president and ceo | S-Sale | 16,381 | $13.62 | $223K | Filing |
| 2026-02-18 | Fenton Mary Kay | officer: chief financial officer | A-Grant/Award | 68,750 | $— | $0 | Filing |
| 2026-02-18 | Michaelson Jennifer | officer: chief scientific officer | A-Grant/Award | 57,500 | $— | $0 | Filing |
| 2026-02-12 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 416 | $12.03 | $5K | Filing |
| 2026-01-22 | Michaelson Jennifer | officer: chief scientific officer | S-Sale | 4,000 | $12.30 | $49K | Filing |
| 2025-12-31 | Fenton Mary Kay | officer: chief financial officer | A-Grant/Award | 27 | $6.49 | $175 | Filing |
| 2025-12-23 | AHMED NADIM | officer: president and ceo | S-Sale | 9,922 | $10.01 | $99K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| MPM BIOIMPACT LLC | 9,731,341 | $177M | +2,083,073 | 2026-06-30 | Filing |
| Lynx1 Capital Management LP | 8,963,500 | $163M | — | 2026-06-30 | Filing |
| BVF INC/IL | 5,750,683 | $105M | — | 2026-06-30 | Filing |
| BlackRock, Inc. | 5,232,766 | $95M | +782,800 | 2026-06-30 | Filing |
| STATE STREET CORP | 3,668,627 | $67M | +1,124,512 | 2026-06-30 | Filing |
| Kynam Capital Management, LP | 3,114,132 | $57M | — | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,614,066 | $48M | +131,032 | 2026-06-30 | Filing |
| RTW INVESTMENTS, LP | 2,364,347 | $43M | +658,387 | 2026-06-30 | Filing |
| Siren, L.L.C. | 1,893,410 | $34M | +700,000 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,547,309 | $28M | +179,041 | 2026-06-30 | Filing |
| Blue Owl Capital Holdings LP | 1,539,764 | $28M | -370,000 | 2026-06-30 | Filing |
| Venrock Adviser, LLC | 1,379,965 | $25M | — | 2026-06-30 | Filing |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,082,611 | $20M | -30,192 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 1,046,694 | $19M | +140,666 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,001,598 | $18M | +546,149 | 2026-06-30 | Filing |
| Affinity Asset Advisors, LLC | 875,760 | $16M | +94,500 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 738,741 | $13M | +186,188 | 2026-06-30 | Filing |
| BOONE CAPITAL MANAGEMENT LLC | 704,442 | $13M | +704,442 | 2026-06-30 | Filing |
| Elmind Capital, LP | 690,000 | $13M | +160,000 | 2026-06-30 | Filing |
| MORGAN STANLEY | 629,035 | $11M | +39,552 | 2026-06-30 | Filing |